Your browser doesn't support javascript.
loading
Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis.
Nguyen, Hai Vu; Vandenberg, Cassandra J; Ng, Ashley P; Robati, Mikara R; Anstee, Natasha S; Rimes, Joel; Hawkins, Edwin D; Cory, Suzanne.
Afiliação
  • Nguyen HV; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; and.
  • Vandenberg CJ; Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia.
  • Ng AP; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; and.
  • Robati MR; Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia.
  • Anstee NS; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; and.
  • Rimes J; Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia.
  • Hawkins ED; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; and.
  • Cory S; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; and.
Blood ; 135(13): 1019-1031, 2020 03 26.
Article em En | MEDLINE | ID: mdl-31978211

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Proteínas Proto-Oncogênicas c-myc / Apoptose / Linfoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Proteínas Proto-Oncogênicas c-myc / Apoptose / Linfoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article